Vir Biotechnology Inc (VIR)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
7.15 +0.15 (+2.14%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 7.15 unch (unch) 16:12 ET
for Fri, Mar 14th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
Sales | 12,374 | 2,380 | 3,075 | 56,376 | 16,787 |
Cost of Goods | 684 | 50 | 52 | 59 | 798 |
Gross Profit | 11,690 | 2,330 | 3,023 | 56,317 | 15,989 |
Operating Expenses | 129,524 | 233,684 | 161,705 | 136,457 | 155,803 |
Operating Income | -117,150 | -231,304 | -158,630 | -80,081 | -139,016 |
Other Income | 12,475 | 17,764 | 18,740 | 15,081 | 18,259 |
Pre-tax Income | -104,675 | -213,540 | -139,890 | -65,000 | -120,757 |
Income Tax | -86 | 177 | -1,512 | 276 | -4,784 |
Net Income Continuous | -104,589 | -213,717 | -138,378 | -65,276 | -115,973 |
Net Income | $-104,589 | $-213,717 | $-138,378 | $-65,276 | $-115,973 |
EPS Basic Total Ops | -0.77 | -1.56 | -1.02 | -0.48 | -0.86 |
EPS Basic Continuous Ops | -0.77 | -1.56 | -1.02 | -0.48 | -0.86 |
EPS Diluted Total Ops | -0.77 | -1.56 | -1.02 | -0.48 | -0.86 |
EPS Diluted Continuous Ops | -0.77 | -1.56 | -1.02 | -0.48 | -0.86 |
EPS Diluted Before Non-Recurring Items | N/A | -1.56 | -1.02 | -0.48 | -0.86 |
EBITDA(a) | $-112,096 | $-228,054 | $-151,733 | $-75,326 | $-133,186 |